INSM - Company ID 0001104506
The table below shows INSMED Inc's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $606.42M | $363.71M | $305.21M | $245.36M | $188.46M | $164.41M |
| Cost of revenue | $122.94M | $85.74M | $65.57M | $55.13M | $44.15M | $39.87M |
| Gross profit | - | - | - | - | - | - |
| R&D | $771.09M | $598.37M | $571.01M | $397.52M | $272.74M | $181.16M |
INSMED Inc reported annual revenue of $606.42M for fiscal year 2025. That is up 66.7% from $363.71M in fiscal 2024. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $701.17M |
| $461.12M |
| $344.50M |
| $265.78M |
| $234.27M |
| $203.61M |
| Operating income | -$1.25B | -$878.25M | -$709.63M | -$457.32M | -$375.09M | -$265.23M |
| Income tax | $5.03M | $3.71M | $2.56M | $1.38M | -$1.76M | $1.40M |
| Net income | -$1.28B | -$913.77M | -$749.57M | -$481.53M | -$434.65M | -$294.09M |
| EPS (diluted) | -$6.42 | -$5.57 | -$5.34 | -$3.91 | -$3.88 | -$3.01 |